Brad is co-leader of Barclay Damon's Health Care Controversies Team. He concentrates his national practice on providing legal services to clients in the pharmaceutical industry, including independent retail, chain, specialty, infusion and compounding pharmacies, as well as health care systems. Brad also represents wholesalers, manufacturers, technology companies, and others with legal, regulatory, and compliance issues in the pharmacy space. He represents other health care providers, including physicians, laboratories, and durable medical equipment (DME) providers, with issues relating to network participation and reimbursement issues.
Brad counsels clients nationwide on issues with health plans, pharmacy benefit managers (PBMs), and government entities, such as credentialing and enrollment, audits and investigations, network terminations, and reimbursement disputes. Specifically, Brad has assisted providers in overturning enrollment denials and with the recovery of millions of dollars for providers following challenges to audit findings or improper reimbursements.
Brad also counsels clients in matters pertaining to contract management, best practices, and other business-related issues, with a focus on those entities operating in the pharmaceutical industry. For example, Brad assists clients in understanding and evaluating risks with data privacy and security, marketing and payment models, and interplay with other agreements entered by the client.
Brad represents entities in pharmacy- and other health care-related transactions, including those involving private and chain sales or private equity. Brad also assists entities with corporate formation, due diligence, licensing, and credentialing.